CVATOTCAgricultural ServicesUS GAAP · USD

Cavitation Technologies, Inc.

Cavitation Technologies, Inc. develops and commercializes cavitation-based processing systems built around its Nano Reactor® platform and related intellectual property. Historically, the company sold reactors into vegetable oil refining through a strategic partner, but after assigning those patents to Desmet it shifted toward licensing and new applications. Management is now trying to monetize the technology in water and wastewater treatment, oilfield water remediation, agriculture disinfection, alcoholic beverages, and new Hydro-Plasma applications. The business is still in an early commercialization phase and remains dependent on converting its patent portfolio and licenses into repeatable revenue streams.

Revenue0.0m USD
−98.5 %y/y
Operating profit (EBIT)-1.4m USD
−40.6 %y/y
EBIT margin-46,266.7%
−45,780.5 ppy/y
Net income-1.4m USD
−1,142.5 %y/y

Fiscal year 2026 · change from previous year

Development 2021–2026

-2-1012m USD2021: 0.56 m USD2021: EBIT -0.75 m USD20212022: EBIT -0.30 m USD20222023: EBIT -0.89 m USD20232024: 1.4 m USD2024: EBIT 0.44 m USD20242025: 0.20 m USD2025: EBIT -0.99 m USD20252026: 0.00 m USD2026: EBIT -1.4 m USD20260.00-1.4
RevenueOperating profit (EBIT)

Business

Share of revenue
Nano Reactor® equipment55 %

Cavitation-based reactor devices and systems sold or licensed for industrial processing applications.

Water treatment and remediation20 %

Applications of the technology for produced water, frac water, recycling, purification, and disinfection.

Alcoholic beverage technology10 %

Licensed use of the technology for brewing, distillation, enhancement, and related beverage processing.

Licensing and royalties10 %

Royalty, usage-fee, and other license-based monetization of the patent portfolio and know-how.

New technology development5 %

Hydro-Plasma and other next-generation process technologies under development.

Customers

The company’s historical customers were industrial buyers of Nano Reactor® equipment, especially a strategic distributor/partner such as Desmet in vegetable oil refining. Its current target customers are operators that need water treatment, remediation, recycling, and purification solutions, including oilfield wastewater users in the Permian Basin. Management also targets agricultural users that need water remediation and disinfection, as well as beverage companies that can use the licensed technology in brewing and alcoholic beverage enhancement. In addition, the company can monetize through licensing partners and usage-fee arrangements rather than only direct equipment sales. These customers are attracted by the potential to reduce chemical usage, improve water quality, and create process efficiencies in fluid-intensive operations.

Industrial reactor customers/distributors

Buy Nano Reactor® systems for resale or use in industrial processing, historically including Desmet-related vegetable oil refining applications.

Oilfield water treatment operators

Use the technology for produced-water and frac-water remediation in the Permian Basin and similar oilfield environments.

Agriculture water users

Buy or license solutions for water remediation and disinfection in agricultural operations.

Alcoholic beverage processors

Use licensed technology for brewing, distillation, enhancement, and related beverage processing applications.

Licensing and royalty partners

Partners such as ABI or other licensees that pay royalties, usage fees, consulting, or leasing-related amounts.

Strategy

Management’s near-term strategy is to replace the lost vegetable-oil-refining revenue stream with new applications of the Reserved Grant Back License. The company is prioritizing water and wastewater processing, recovery, recycling, and purification, especially oilfield wastewater, because those markets can validate the technology and create recurring commercial demand. It is also pursuing agriculture disinfection, alcoholic beverage licensing, and Hydro-Plasma development to broaden the addressable market beyond a single end market. Because the company has limited cash and a going-concern risk, financing and disciplined commercialization are central to executing the strategy.

Convert water-treatment trials into commercial salesShort term

The company needs a new revenue engine after the Desmet patent assignment reduced reactor sales tied to vegetable oil refining.

Monetize the licensed fields through royalties and usage feesMedium term

Licensing can create recurring revenue without requiring the company to manufacture all end products itself.

Develop new applications beyond oil and vegetable oil refiningMedium term

Diversification reduces dependence on a single legacy market and expands the patent portfolio’s economic value.

Secure financing to sustain operationsShort term

The company has limited cash and may need additional capital before new applications generate meaningful revenue.

Geography

The company is headquartered in the United States and its reported operations, suppliers, and commercialization efforts are centered there. Management describes the Permian Basin as a key target market for water treatment and remediation, which ties the business to U.S. oilfield activity. The company also states that it has issued patents internationally and retains worldwide licenses in its licensed fields, so the addressable market is not limited to the U.S. Even so, the current revenue base appears concentrated in U.S.-linked counterparties and projects, making execution in domestic pilot and commercialization programs especially important.

Risks

The biggest company-specific risk is that the business has not yet proven a durable replacement for the revenue lost after assigning vegetable-oil-refining patents to Desmet. Commercial acceptance of the water-treatment technology has been slow, and management itself notes that additional trials and customer adaptation are still needed before meaningful sales can emerge. The company also faces going-concern and financing risk because cash resources are limited and future debt or equity funding is not assured. More broadly, it is exposed to customer concentration, supplier dependence without long-term contracts, and the execution risk typical of early-stage industrial technology commercialization.

Sorted by severity
Going-concern and financing shortfallCritical

The company says continued operations depend on implementing the business plan and obtaining additional funding if needed.

Exposure: Corporate liquidity

Loss of legacy reactor revenue after patent assignment to DesmetHigh

The company expects sales of Nano reactors to Desmet to be significantly reduced, removing a historical revenue source.

Exposure: Historical core revenue stream

Slow adoption of water-treatment technologyHigh

Management states acceptance has been slow and additional trials are still underway before broader sales can begin.

Exposure: New commercial applications

Customer concentrationHigh

A large portion of historical revenue came from sales to a strategic partner/distributor, increasing dependence on a small number of buyers.

Exposure: Revenue concentration

Supplier disruptionMedium

Reactor components are sourced from domestic and international suppliers without long-term commitments, creating replacement and lead-time risk.

Exposure: Manufacturing inputs

Accounting

Judgemental items
Revenue recognition for reactor sales

Revenue is recognized when products ship, so timing of deliveries directly affects reported quarterly sales.

Impact: Can create volatile revenue and gross margin patterns

Usage-fee revenue

Fees are recognized based on actual usage, which depends on customer activity and measurement accuracy.

Impact: Adds variability and judgment to revenue timing

Patent assignment gain

The prior-year gain on patent assignment materially boosted reported income and reduced comparability.

Impact: Can obscure underlying operating performance

Impairment and valuation estimates

Management uses estimates for impairment analysis, contingent liabilities, and deferred tax asset valuation allowances.

Impact: Can materially change reported assets, liabilities, and earnings

Publicly listed companies with a comparable business focus.

Last updated: 28/04/2026

Cavitation Technologies, Inc. (OTC) – Agricultural Services | Financial Analysis – Clarifo